Merck to acquire San Diego biotech company for $10.8B : vima

Merck announced April 16 that it entered into a definitive agreement to acquire Prometheus Biosciences Inc. for approximately $10.8 billion. 

Related Keywords

California , United States , Robert Davis , Mark Mckenna , Imago Biosciences Inc , Exchange Commission , Latham Watkins , Centerview Partners , Goldman Sachs Co , Prometheus Biosciences Inc , Wharton Garrison , Morgan Stanley Co , San Diego Based , Prometheus Biosciences , Rahway Based Merck , Hart Scott Rodino Antitrust Improvements , Goldman Sachs , Imago Biosciences ,